[HTML][HTML] Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine
…, J Hadler, LH Harrison, NM Bennett… - … England Journal of …, 2003 - Mass Medical Soc
Background In early 2000, a protein–polysaccharide conjugate vaccine targeting seven
pneumococcal serotypes was licensed in the United States for use in young children. Methods …
pneumococcal serotypes was licensed in the United States for use in young children. Methods …
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine
…, J Hadler, LH Harrison, NM Bennett… - The Journal of …, 2010 - academic.oup.com
BackgroundChanges in invasive pneumococcal disease (IPD) incidence were evaluated
after 7 years of 7-valent pneumococcal conjugate vaccine (PCV7) use in US children …
after 7 years of 7-valent pneumococcal conjugate vaccine (PCV7) use in US children …
[HTML][HTML] Bacterial meningitis in the United States, 1998–2007
…, MM Farley, A Reingold, NM Bennett… - … England Journal of …, 2011 - Mass Medical Soc
Background The rate of bacterial meningitis declined by 55% in the United States in the early
1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was …
1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was …
[HTML][HTML] Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions …
NM Bennett, CG Whitney, M Moore, T Pilishvili… - 2012 - stacks.cdc.gov
MMWR. Morbidity and mortality weekly report 2012 Oct 12;61(40):816-9. Reported by:
Nancy M. Bennett, MD, Advisory Committee on Immunization Practices Pneumococcal Work …
Nancy M. Bennett, MD, Advisory Committee on Immunization Practices Pneumococcal Work …
[HTML][HTML] Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae
…, AR Thomas, LH Harrison, NM Bennett… - … England Journal of …, 2006 - Mass Medical Soc
Background Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for
infants in the United States in 2000, are responsible for most penicillin-resistant infections. …
infants in the United States in 2000, are responsible for most penicillin-resistant infections. …
Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19) …
…, EJ Anderson, I Armistead, NM Bennett… - Clinical infectious …, 2021 - academic.oup.com
Background Currently, the United States has the largest number of reported coronavirus
disease 2019 (COVID-19) cases and deaths globally. Using a geographically diverse …
disease 2019 (COVID-19) cases and deaths globally. Using a geographically diverse …
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
ContextA conjugate vaccine targeting 7 pneumococcal serotypes was licensed for young
children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7-…
children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7-…
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite …
…, R Lynfield, C Lexau, NM Bennett… - The Lancet Infectious …, 2015 - thelancet.com
Background In 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced
in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) …
in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) …
[HTML][HTML] Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged≥ 65 years: recommendations of …
S Tomczyk, NM Bennett, C Stoecker, R Gierke… - MMWR Morb Mortal …, 2014 - cdc.gov
On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended
routine use of 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth …
routine use of 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth …
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study
…, AC Nyquist, KA Gershman, M Vazquez, NM Bennett… - The Lancet, 2006 - thelancet.com
Background When seven-valent pneumococcal conjugate vaccine was introduced in the
USA, many children were vaccinated on schedules that differed from those tested in clinical …
USA, many children were vaccinated on schedules that differed from those tested in clinical …